HALOZYME THERAPEUTICS, INC. (HALO) › EPS (Diluted)HALOZYME THERAPEUTICS, INC. (HALO) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2015: $-0.252016: $-0.812017: $0.452018: $-0.562019: $-0.502020: $0.912021: $2.742022: $1.442023: $2.102024: $3.432025: $2.56$2.562015EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$2.56-25.4%2024$3.43+63.3%2023$2.10+45.8%2022$1.44-47.4%2021$2.74+201.1%2020$0.91+282.0%2019$-0.50+10.7%2018$-0.56-224.4%2017$0.45+155.6%2016$-0.81-224.0%2015$-0.25—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share